TotalMarketCap

GeoVax Labs

GOVXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.947 M

$0.16 -5.06%

Close of 6 Nov 2026

As of 6 Nov 2026, GeoVax Labs (GOVX) has a market capitalization of $1.95M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$21.5M

Loss-making

Shares outstanding

7,369,243

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #482Revelation BiosciencesREVB$2.03M
  2. #483Purple BiotechPPBT$2.02M
  3. #484GeoVax LabsGOVX$1.95M
  4. #485EnlivexENLV$1.95M
  5. #486Propanc BiopharmaPPCB$1.72M

What if GeoVax Labs were worth as much as…

Open the what-if tool →

Gold $28.2T

$2,312,627

Per share 14,499,230× higher

Bitcoin $1.53T

$125,132.23

Per share 784,528× higher

Apple $5.02T

$410,797.44

Per share 2,575,533× higher

Or at a round number

$5.00M$10.0M$20.0M$50.0M

Where these numbers come from

Share counts and financials for GeoVax Labs are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.